Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: A randomized placebo-controlled clinical trial

The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · see citing works

Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )

Segal, D. L. (2010) · Wiley eBooks · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,683 · see citing works

WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects

(2001) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2001.tb01222.x · Cited by 3,515 · see citing works

Ethical principles for medical research involving human subjects

Eckstein, S. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511550089.027 · Cited by 2,592 · see citing works

The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency

Kim, S. W., Dysken, M. W., Pheley, A. M., & Hoover, K. M. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90039-6 · Cited by 2,361 · see citing works

DECLARATION OF HELSINKI.

Gandevia, B., & Tovell, A. (1964) · PubMed · Cited by 2,068 · see citing works

Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects

World Medical Association (2009) · Jahrbuch für Wissenschaft und Ethik · doi:10.1515/9783110208856.233 · Cited by 1,119 · see citing works

Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron

Frederickson, C. J., Suh, S. W., Silva, D., Frederickson, C. J., & Thompson Richard, B. (2000) · Journal of Nutrition · doi:10.1093/jn/130.5.1471s · Cited by 866 · see citing works

ZINC AND BRAIN INJURY

Choi, D. W., & Koh, J. Y. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.347 · Cited by 754 · see citing works

Zinc Selectively Blocks the Action of N -Methyl-D-Aspartate on Cortical Neurons

Peters, S., Koh, J., & Choi, D. W. (1987) · Science · doi:10.1126/science.2883728 · Cited by 667 · see citing works

Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc.

Smart, T., Xie, X., & Krishek, B. (1994) · Progress in neurobiology · doi:10.1016/0301-0082(94)90082-5 · Cited by 459 · see citing works

Movement of zinc and its functional significance in the brain

Takeda, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00044-8 · Cited by 416 · see citing works

D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder

Kushner, M. G., Kim, S. W., Donahue, C. B., THURAS, P. D., Adson, D. E., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384 · see citing works

Augmentation of Behavior Therapy With <scp>d</scp> -Cycloserine for Obsessive-Compulsive Disorder

Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358 · see citing works

Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat

Frederickson, C. J., Klitenick, M. A., Manton, W. I., & Kirkpatrick, J. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90858-2 · Cited by 346 · see citing works

Glutamatergic Dysfunction in OCD

Chakrabarty, K., Bhattacharyya, S., Christopher, R., & Khanna, S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300733 · Cited by 344 · see citing works

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial

Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314 · see citing works

Atypical neural messengers

Barañano, D. E., Ferris, C. D., & Snyder, S. H. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01716-1 · Cited by 293 · see citing works

Zn2+: an endogenous modulator of ligand- and voltage-gated ion channels

HARRISON, N., & Gibbons, S. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90152-x · Cited by 282 · see citing works

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

Pittenger, C., Krystal, J. H., & Coric, V. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.006 · Cited by 223 · see citing works

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

Arnold, P., Rosenberg, D., Mundo, E., Tharmalingam, S., Kennedy, J., & Richter, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1847-1 · Cited by 202 · see citing works

An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder

Grant, P., Lougee, L., Hirschtritt, M., & Swedo, S. E. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0021 · Cited by 197 · see citing works

Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice

Rosa, A. O., Lin, J. H. X., Calixto, J. Β., Santos, A. R. S., & Rodrigues, A. L. S. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00069-x · Cited by 183 · see citing works

Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc

Ilouz, R., Kaidanovich‐Beilin, O., Gurwitz, D., & Eldar-Finkelman, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00636-8 · Cited by 161 · see citing works

Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

Aboujaoude, E. N., Barry, J. J., & Gamel, N. N. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318192e9a4 · Cited by 137 · see citing works

Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders

Gould, T. D., Picchini, A. M., Einat, H., & Manji, H. K. (2006) · Current Drug Targets · doi:10.2174/1389450110607011399 · Cited by 129 · see citing works

Zinc inhibits glutamate release via activation of pre‐synaptic KATP channels and reduces ischaemic damage in rat hippocampus

Bancila, V., Nikonenko, I., Dunant, Y., & Bloc, A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02587.x · Cited by 124 · see citing works

Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion

Heinel, L. A., Rubin, S., Rosenwasser, R. H., Vasthare, U. S., & Tuma, R. F. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90010-8 · Cited by 96 · see citing works

A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity

Starck, G., Ljungberg, M., Nilsson, M. K. L., Jönsson, L., Lundberg, S., Ivarsson, T., Ribbelin, S., EKHOLM, S. E., Carlsson, A., Forssell-Aronsson, E. B., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0045-4 · Cited by 94 · see citing works

Zinc Supplementation Ameliorates Electromagnetic Field-Induced Lipid Peroxidation in the Rat Brain

Bediz, C. Ş., Baltacı, A. K., Moğulkoç, R., & Menevşe, E. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.208.133 · Cited by 67 · see citing works

Mechanisms contributing to antidepressant zinc actions.

Nowak, G., & Szewczyk, B. (2002) · PubMed · Cited by 50 · see citing works

Pinealectomy and melatonin administration in rats: Their effects on plasma leptin levels and relationship with zinc

Baltacı, A. K., & Moğulkoç, R. (2007) · Acta Biologica Hungarica · doi:10.1556/abiol.58.2007.4.1 · Cited by 39 · see citing works

Effects of Zinc Deficiency and Pinealectomy on Cellular Immunity in Rats Infected with Toxoplasma gondii

Baltacı, A. K., Moğulkoç, R., Bediz, C. Ş., & Pekel, A. (2005) · Biological Trace Element Research · doi:10.1385/bter:104:1:047 · Cited by 21 · see citing works

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works

Eating Disorders: An Evolutionary Psychoneuroimmunological Approach

Rantala, M. J., Luoto, S., Krama, T., & Krams, I. A. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02200 · Cited by 73 · see citing works

Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action

Nowak, G. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.01.015 · Cited by 65 · see citing works

Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy

Onaolapo, O. J., Ademakinwa, O. Q., Olalekan, T. O., & Onaolapo, A. Y. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4666-x · Cited by 45 · see citing works

Pharmacological Augmentations of SRIs for Obsessive Compulsive Disorder

Leppink, E. W., & Grant, J. E. (2017) · Wiley eBooks · doi:10.1002/9781118890233.ch16 · Cited by 43 · see citing works

SERS activity and spectroscopic properties of Zn and ZnO nanostructures obtained by electrochemical and green chemistry methods for applications in biology and medicine

Proniewicz, L. M., Tąta, A., Wójcik, A., Starowicz, M., Pacek, J., & Molenda, M. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp03517c · Cited by 31 · see citing works

Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial

Mortazavi, M., Farzin, D., Zarhghami, M., Hosseini, S. H., Mansoori, P., & Nateghi, G. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs-853 · Cited by 26 · see citing works

Nutritional and herbal supplements in the treatment of obsessive compulsive disorder

Karcı, C. K., & Çelik, G. G. (2020) · General Psychiatry · doi:10.1136/gpsych-2019-100159 · Cited by 24 · see citing works

Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time

Kotzalidis, G. D., CASALE, A. D., Simmaco, M., Pancheri, L., Brugnoli, R., Paolini, M., Gualtieri, I., Ferracuti, S., Savoja, V., Cuomo, I., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666181026163922 · Cited by 20 · see citing works

Lifestyle Interventions in the Treatment of Obsessive-Compulsive and Related Disorders: A Systematic Review

Brierley, M.-E. E., Thompson, E. M., Albertella, L., & Fontenelle, L. F. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000988 · Cited by 14 · see citing works

Dietary zinc supplement militates against ketamine-induced behaviours by age-dependent modulation of oxidative stress and acetylcholinesterase activity in mice

Onaolapo, O. J., Jegede, O. R., Adegoke, O., Ayinde, M. O., Akeredolu, O. M., & Onaolapo, A. Y. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00003-2 · Cited by 15 · see citing works

A glance at…nutritional antioxidants and testosterone secretion

Glade, M. J., Smith, K., & Meguid, M. M. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.019 · Cited by 13 · see citing works

Is There A Role For Lifestyle Interventions In Obsessive-Compulsive And Related Disorders?

Fontenelle, L. F., Zeni‐Graiff, M., Quintas, J. N., & Yücel, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180104150854 · Cited by 11 · see citing works

Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study

Sarris, J. J., Byrne, G. J., Oliver, G., Cribb, L., Blair‐West, S., Castle, D. J., Dean, O. M., Camfield, D., Brakoulias, V., Bousman, C., et al. (2021) · CNS Spectrums · doi:10.1017/s1092852921000638 · Cited by 12 · see citing works

Integrative Medicine and Mood, Emotions and Mental Health

Shah, A. K., Becicka, R., Talen, M. R., Edberg, D., & Namboodiri, S. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.02.003 · Cited by 9 · see citing works

Dietary quality and nutrient intake in adults with obsessive–compulsive disorder

Nguyen, T. P., Cribb, L., Ng, C. H., Byrne, G. J., Castle, D. J., Brakoulias, V., Blair‐West, S., Oliver, G., Ee, C., Dean, O. M., et al. (2021) · BJPsych Open · doi:10.1192/bjo.2021.1039 · Cited by 9 · see citing works

Role of Micronutrients in Neurological Development

Ravikumar, N., Krishnamurthi, D., & Venkata, S. G. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-8158-5_9 · Cited by 6 · see citing works

Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial

Mortazavi, M., Farzin, D., Zarhghami, M., Hosseini, S. H., Mansoori, P., & Nateghi, G. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.853 · Cited by 6 · see citing works

Nutrition and Psychiatric Disorders: Focus on Schizophrenia

Mansour, H. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-5021-6_15 · Cited by 3 · see citing works

COMPARING THE EFFECT OF SECOND-GENERATION ANTIPSYCHOTICS VERSUS SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN REFRACTORY OBSESSIVE-COMPULSIVE DISORDER: A SYSTEMATIC REVIEW OF THE PAST, PRESENT, AND FUTURE CLINICAL TRIALS

Sayyah, M., & Rahim, F. (2016) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i1.14528 · Cited by 1 · see citing works

Novel Marine-Derived Natural Products for the Treatment of Depressive Disorder

Kamala, K., Sivaperumal, P., Dharani, G., Ramachandran, S., & Ganapathy, D. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-8158-5_13 · Cited by 1 · see citing works

Anatomy and Function of Synaptic Zinc in the Striatum

Thackray, S. E. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/24841

Alternative Treatments for Obsessive-Compulsive Disorder: Nutraceuticals and Lifestyle Interventions

Sarris, J. J., & Oliver, G. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.023

Kombinationen mit Psychopharmaka in der Behandlung von Angst- und Zwangsstörungen

Volz, H. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_8

Nutritional Deficiencies in Obsessive-Compulsive Disorder and Possible Treatment Interventions

Sethi, P., Kumar, S., Prajapati, A., Irfanullah, Z., Jatchavala, C., Vadivel, R., & Hayek, S. E. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-5021-6_9

Chapter 52. Treatment of Obsessive-Compulsive Disorder

Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1 · see citing works

Protocol for a Randomized Controlled Trial of Broad-spectrum Vitamin and Micronutrient Supplementation in Children and Adolescents with Irritability, Impulsivity or Compulsivity (VANTASTIC Study) (Preprint)Preprint

Dietrich, A., Schlipf, M., Berg, R., Mechler, K., Rucklidge, J. J., Vásquez, A. A., Rommelse, N. N. J., Banaschewski, T., Hoekstra, P. J., & Haege, A. (2025) · doi:10.2196/preprints.87761

Nutraceuticals and obsessive-compulsive disorder therapy

Mohammadi, A. H., Amin, N., Tavousi, S. A., Mahabady, M. K., Aschner, M., & Mirzaei, H. (2026) · Advances in neurotoxicology · doi:10.1016/bs.ant.2026.03.001

A preliminary randomized double–blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive–compulsive disorder

Sayyah, M., Boostani, H., Pakseresht, S., & Malayeri, A. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.01.019 · Cited by 70 · see citing works

Efficacy and safety of selenium as an add-on therapy to selective serotonin reuptake inhibitors in patients with obsessive compulsive disorder – a prospective randomised open-label study

Sivagami, R., Gautham, M., & Firoze, M. (2026) · Asian Journal of Medical Sciences · doi:10.71152/ajms.v17i6.5251

Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder

Swerdlow, N. R., & Andia, A. M. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.12.1637b · Cited by 4 · see citing works

Fluoxetine Adjunctive Therapy for Obsessive-Compulsive Symptoms Associated With Olanzapine in Schizophrenic Patients

de Figueiredo, T. C., Segenreich, D., & Mattos, P. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000521 · Cited by 5 · see citing works

Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial

Shalbafan, M., Malekpour, F., Najafabadi, B. T., Ghamari, K., Dastgheib, S. A., Mowla, A., Shirazi, E., Ardebili, M. E., Ghazizadeh‐Hashemi, M., & Akhondzadeh, S. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119878177 · Cited by 35 · see citing works